Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma
about
Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.A pilot study of paclitaxel combined with gemcitabine followed by interleukin-2 and granulocyte macrophage colony-stimulating factor for patients with metastatic melanoma.The role of IL-2 in the activation and expansion of regulatory T-cells and the development of experimental autoimmune encephalomyelitisResveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells.Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells.Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein α by microRNA-690.Review of natural compounds for potential skin cancer treatment.Use of Polyphenolic Compounds in Dermatologic Oncology.Modification of Antitumor Immunity and Tumor Microenvironment by Resveratrol in Mouse Renal Tumor Model.A Potential Mechanism for the Anti-Apoptotic Property of Koumine Involving Mitochondrial Pathway in LPS-Mediated RAW 264.7 Macrophages.An in vivo and in vitro study: High-dosage Danshen injection induces peripheral vascular endothelial cells injury.Resveratrol Improves Endothelial Progenitor Cell Function through miR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo.
P2860
Q33750847-005A60EF-11F1-41DA-B2BB-F39067BF662EQ33774512-862666A8-8968-4958-872F-0CC885416A20Q35207111-6D6DA740-E90A-4414-BECE-ACA19C1CE1FFQ35613040-9EFD9CED-3352-47A7-9133-FEC3B5574BB9Q35970488-FDDC5F45-8567-4BBB-846E-99215B99A08EQ36524227-E2CB2560-F468-4985-9175-03B7B3BF5B56Q36640032-8E6CC833-3747-4E0A-89A5-BDE6AFB5608BQ36914176-77183313-9965-4676-8DE6-D2220553FD36Q37227553-6CE09D17-5327-4D53-B87B-C0488F3ACB92Q37415572-7C2A09E9-8FDF-4159-A450-01BDF04B478AQ38237757-1FDE48D8-B1B0-40F2-9ED0-3BA417D9C522Q38831160-CF5D526F-715D-42DA-AC6B-12AD448C1330Q38918196-93E3BF2D-C471-49DE-B3CC-4D06725DFED5Q46481769-6F2BB29D-502F-4455-94D2-633C8DC6C466Q46714539-95242BA1-E8D1-4CAF-9FBB-5F4D20C0BAB4Q49981014-8AAEB41B-FC9D-43FB-8F05-FBE94BA257E5
P2860
Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@ast
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@en
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@nl
type
label
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@ast
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@en
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@nl
prefLabel
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@ast
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@en
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@nl
P2093
P2860
P1433
P1476
Resveratrol prevents endotheli ...... kin-2 therapy against melanoma
@en
P2093
Hongbing Guan
Mitzi Nagarkatti
Narendra P Singh
Prakash S Nagarkatti
Udai P Singh
P2860
P304
P356
10.1371/JOURNAL.PONE.0035650
P407
P577
2012-04-20T00:00:00Z